First Western Trust Bank Halozyme Therapeutics, Inc. Transaction History

First Western Trust Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $6,526 - $7,881	-179 Reduced 1.13%	15,616 $596,000
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $10,113 - $12,939	334 Added 2.16%	15,795 $569,000
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $2,398 - $4,066	-73 Reduced 0.47%	15,461 $590,000
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $622,292 - $923,340	15,534 New	15,534 $883,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of First Western Trust Bank, based on Form 13F filings with the SEC.

Stay updated on First Western Trust Bank with notifications on news.